Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Delgocitinib Cream in Chronic Hand Eczema
NCT05486117Phase 1Completed
- Sponsor
- LEO Pharma
- Start
- Sep 2022
- Primary completion
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of delgocitinib in chronic hand eczema (CHE), sponsored by LEO Pharma. Primary endpoints: Area under the concentration-time curve 0-12 hours post dose at Day 8 and Maximum observed concentration at Day 8. Started Sep 2022; status: completed.
02
Drugs
delgocitinib
03
Conditions
chronic hand eczema (CHE)
Beyond the preview
Go deeper on NCT05486117.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05486117.